Christopher Barrett, DPM
Podiatrist · Chester, PANPI 1609922772
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (54.7%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. KCI USA, Inc. accounts for 88.0% of it on its own, with 20 other manufacturers making up the rest. Reporting peaked in 2019 at $128,788 and has fallen 99.4% since, to $814 in 2024. Among podiatrist clinicians in PA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 435 payments — averaging $527.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- KCI USA, Inc.$202K
- Organogenesis Inc.$20K
- Urgo Medical North America, LLC$5K
- Medline Industries LP$800
- Smith+Nephew$658
- Paratek Pharmaceuticals, Inc.$158
- plus $829 from 15 others
What the payments were for
- Consulting fees$27,48812%
- Speaking & faculty fees$125,46655%
- Travel & lodging$63,36728%
- Food & beverage$8,8004%
- Education$4,1772%
- Entertainment$1180%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| KCI USA, Inc. | 260 | $201,888 |
| Organogenesis Inc. | 79 | $19,605 |
| Urgo Medical North America, LLC | 5 | $5,477 |
| Medline Industries LP | 1 | $800 |
| Smith+Nephew | 47 | $658 |
| Paratek Pharmaceuticals, Inc. | 7 | $158 |
| Musculoskeletal Transplant Foundation Inc. | 4 | $152 |
| Misonix Inc | 4 | $99 |
| AbbVie | 4 | $90 |
| Bioventus LLC | 3 | $78 |
| Merck | 4 | $72 |
| Reapplix Inc. | 3 | $65 |
| Convatec Inc. | 3 | $55 |
| Melinta Therapeutics, LLC | 2 | $46 |
| Lifenet Health | 2 | $42 |
| Nabriva Therapeutics, PLC | 2 | $34 |
| Cumberland Pharmaceuticals, Inc. | 1 | $30 |
| Hartmann USA, Inc. | 1 | $21 |
| Kerecis Limited | 1 | $19 |
| Acera Surgical, Inc. | 1 | $17 |
| Next Science LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SNAP$149,817
- ACTIV.A.C.$25,641
- V.A.C. DERMATAC$19,615
- KERRACEL AG$14,029
- PROMOGRAN PRISMA$11,222
- V.A.C. VERAFLO$10,699
- PREVENA$10,431
- KerraMax$10,287
- Tegaderm$10,089
- PuraPly$9,979
- Puraply Antimicrobial$7,498
- Curos$4,239
- Cavilon$4,239
- UrgoK2$3,500
- V.A.C. VERAFLO CLEANSE CHOICE$2,488
- Vashe$1,950
- KERRAMAX CARE$1,800
- PROMOGRAN$1,800
- Cavilon Advanced Skin Protectant$1,738
- ACTIVAC$1,736
How this compares
$229,415 in reported general payments places this provider in the 95th percentile of 445 podiatrist providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other podiatrist in Chester
- Mark HofbauerBelle Vernon$1.1M
- Daniel PerezPhiladelphia$434K
- Alan CatanzaritiPittsburgh$80K
- John StarinskiPen Argyl$74K
- Kwasi KwaaduPhiladelphia$65K
- Luke CicchinelliPhiladelphia$62K
- James McGuirePhiladelphia$60K
- John SchelandClarks Summit$54K
- John LapelusaYork$54K
- Ellianne NasserScranton$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.